This project will carry out in parallel pharmacological studies to characterize receptor-selective CCK-related peptide actions on gastrointestinal transit in mice and on regional transit in rats, analgesia, food ingestion, and on gastrointestinal motility, and patterns of motility in vivo associated with a stress response and identification of central and peripheral mediators of the response. In our peptide design and synthesis program supported by this grant, we have developed some extraordinarily promising lead compounds that we will refine chemically to generate highly selective agonists at CCKA and CCKB receptors. In combination with existing nonpeptide antagonists, such as L-364,718 and L- 365,260, plus natural and synthetic analogues of CCK, we will define the motility responses, transit consequences and appetite regulating activity of brain and peripheral CCKA, CCKB and gastrin receptor. Moreover, our preliminary studies provide strong evidence for multiple subtypes of CCKB receptors in the brain and in the periphery. Different CCKB subtypes in brain may be linked to inhibition of food ingestion and g.i. antitransit effects. A subtype of CCKB receptor may be associated with peripheral antiappetite effects of CCK. The in vitro and in vivo models to be employed are familiar techniques in our laboratory. Specifically, we will measure motility in unanesthetized rats of the stomach, small intestine, cecum and colon and correlate motility changes with alterations in transit (propulsion) in each of these regions after central (i.c.v.) and peripheral (i.v.) administration of receptor-selective peptide agonists. We will also assess effects of the peptides on consumption of a highly palatable meal to establish whether CCKA and CCKB receptors mediate satiety effects. Finally, we will characterize specific changes in regional gastrointestinal motility associated with an established model of stress and determine how CRF, opioids, catecholamines, or CCK may be involved in stress-induced motility patterns.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Li, Y; Duckles, S P (1993) Effect of age on vascular content of calcitonin gene-related peptide and mesenteric vasodilator nerve activity in the rat. Eur J Pharmacol 236:373-8
Li, Y J; Duckles, S P (1992) Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur J Pharmacol 210:23-30
Friedman, D J; Krause, D N; Duckles, S P (1992) Complex prejunctional actions of the D2 dopamine agonists N-0923 and N-0924 in the rat tail artery. J Pharmacol Exp Ther 260:568-75
Li, Y J; Duckles, S P (1991) Effect of opioid receptor antagonists on vasodilator nerve actions in the perfused rat mesentery. Eur J Pharmacol 204:323-8
Li, Y J; Duckles, S P (1991) GABA agonists and omega conotoxin GVIA modulate responses to nerve activation of the perfused rat mesentery. Life Sci 48:2331-9
Massamiri, T; Duckles, S P (1991) Interactions of sigma and phencyclidine receptor ligands with the norepinephrine uptake carrier in both rat brain and rat tail artery. J Pharmacol Exp Ther 256:519-24
Li, Y J; Duckles, S P (1991) Differential effects of neuropeptide Y and opioids on neurogenic responses of the perfused rat mesentery. Eur J Pharmacol 195:365-72
Massamiri, T; Duckles, S P (1991) Sigma receptor ligands inhibit rat tail artery contractile responses by multiple mechanisms. J Pharmacol Exp Ther 259:22-9
Nguyen, K; Barrios, V; Duckles, S P (1991) Prejunctional effects of opioids in the perfused mesentery of the rat and rabbit: interactions with alpha 2-adrenoceptors. Life Sci 48:931-8
Massamiri, T; Duckles, S P (1990) Multiple vascular effects of sigma and PCP ligands: inhibition of amine uptake and contractile responses. J Pharmacol Exp Ther 253:124-9

Showing the most recent 10 out of 14 publications